Legal Representation
Attorney
Joseph M. Vanek
USPTO Deadlines
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 20, 2002 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 5, 2001 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jun 28, 2001 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 6, 2001 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 18, 2000 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 24, 2000 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 25, 2000 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 4, 2000 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 12, 1999 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 10, 1999 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 17, 1999 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 9, 1999 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparation for the treatment of heart failure, essential hypertension, prostate cancer, pulmonary hypertension, subarachnoid hemorrhage, asthma, psoriasis and organ reperfusion injury
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005